HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

79 filings reported holding 40637HAF6 - HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1 as of Q1 2024.
HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1 has 70 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $623,774,400 of principal .
Largest 10 bondholders include Linden Advisors LP ($69,023,000 of principal), Calamos Advisors LLC ($63,485,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($51,189,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($49,927,000 of principal), MACKAY SHIELDS LLC ($45,002,000 of principal), LAZARD ASSET MANAGEMENT LLC ($42,339,000 of principal), CAMDEN ASSET MANAGEMENT L P /CA ($30,463,000 of principal), Mirabaud Asset Management (France) SAS ($24,250,000 of principal), Polar Asset Management Partners Inc. ($20,000,000 of principal), and Magnetar Financial LLC ($16,100,000 of principal).
This table shows the top 70 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.